# FDA Inspection 1231030 - Central California Blood Center - February 14, 2024

Source: https://www.keypedia.com/records/fda_inspections/central-california-blood-center/213ec249-a2e5-48bf-b42e-edbfa7928262
Source feed: FDA_Inspections

> FDA Inspection 1231030 for Central California Blood Center on February 14, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1231030
- Company Name: Central California Blood Center
- Inspection Date: 2024-02-14
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1086315 - 2019-04-08](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/c2450d46-0a58-4430-82b7-d142b0019cb6)
- [FDA Inspection 999728 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/0b185f3b-f562-4082-8c0c-2f7ca1a1c151)
- [FDA Inspection 926973 - 2015-05-18](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/9a2b5306-7814-4a80-a0e6-8611206885e6)
- [FDA Inspection 829793 - 2013-04-30](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/99e78b82-531b-41e2-9ec6-319d24547b50)
- [FDA Inspection 728253 - 2011-06-07](https://www.keypedia.com/records/fda_inspections/central-california-blood-center/d329acf1-d22d-4ec4-974c-aca20a0c2ef1)

Company: https://www.keypedia.com/companies/central-california-blood-center/cdb9eb47-661b-4a8c-9976-b9716757419b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d